Inpharma Weekly

, Volume 1547, Issue 1, pp 15–15 | Cite as

Gefitinib effective for patients with NSCLC and mutations in the EGFR gene

Clinical study
  • 4 Downloads

Keywords

Lung Cancer Epidermal Growth Factor Receptor Gefitinib Epidermal Growth Factor Receptor Mutation Advanced NSCLC 

Copyright information

© Adis International Ltd 2006

Personalised recommendations